Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
ENCAVIS AG: A reportable insider transaction was published on 16th August 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 16th August 2023,
The Insider Transaction was made by Lobelia Beteiligungs GmbH 
. The transaction toke place on 16th August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 268.779,66 EUR, based on an average price of 13,44 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 15th August 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 15th August 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 15th August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 273.416,52 EUR, based on an average price of 13,67 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 15th August 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th August 2023,
The Insider Transaction was made by Husmann, Dr. Christoph . The transaction toke place on 15th August 2023. The order was executed at the trading place Tradegate Exchange. . The aggregated volume was 13.420,00 EUR, based on an average price of 13,42 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 15th August 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 15th August 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 15th August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 269.200,00 EUR, based on an average price of 13,46 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 6th June 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 6th June 2023,
The Insider Transaction was made by Lobelia Beteiligungs GmbH . The transaction toke place on 26th May 2023. The order was executed at the trading place XETRA. . The aggregated volume was 299.800,00 EUR, based on an average price of 14,99 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 7th July 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th July 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 6th July 2023. The order was executed at the trading place XETRA. . The aggregated volume was 142.000,00 EUR, based on an average price of 14,20 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 6th July 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th July 2023,
The Insider Transaction was made by Husmann, Dr. Christoph . The transaction toke place on 6th July 2023. The order was executed at the trading place Tradegate Exchange - Berlin. . The aggregated volume was 14.420,00 EUR, based on an average price of 14,42 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 2nd June 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd June 2023,
The Insider Transaction was made by Krüper, Dr. Manfred . The transaction toke place on 31st May 2023. The order was executed at the trading place XETRA. . The aggregated volume was 21.000,00 EUR, based on an average price of 15,00 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th May 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th May 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 26th May 2023. The order was executed at the trading place XETRA. . The aggregated volume was 150.000,00 EUR, based on an average price of 15,00 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 19th April 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 19th April 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 19th April 2023. The order was executed at the trading place XETRA. . The aggregated volume was 75.902,40 EUR, based on an average price of 15,06 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 13th April 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th April 2023,
The Insider Transaction was made by Schmitz, Dr. Rolf Martin . The transaction toke place on 12th April 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 88.200,00 EUR, based on an average price of 15,75 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 13th April 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th April 2023,
The Insider Transaction was made by Schmitz, Dr. Rolf Martin . The transaction toke place on 12th April 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 6.288,00 EUR, based on an average price of 15,72 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 3rd April 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 3rd April 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 3rd April 2023. The order was executed at the trading place XETRA. . The aggregated volume was 465.000,00 EUR, based on an average price of 15,50 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th March 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th March 2023,
The Insider Transaction was made by Testorp Real Estate GmbH . The transaction toke place on 29th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 50.143,20 EUR, based on an average price of 14,75 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th March 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th March 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 30th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 753.000,00 EUR, based on an average price of 15,06 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th March 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 30th March 2023,
The Insider Transaction was made by Schmitz, Dr. Rolf Martin . The transaction toke place on 29th March 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 10.083,50 EUR, based on an average price of 14,40 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th March 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 30th March 2023,
The Insider Transaction was made by Schmitz, Dr. Rolf Martin . The transaction toke place on 29th March 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 189.950,00 EUR, based on an average price of 14,50 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 30th March 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 30th March 2023,
The Insider Transaction was made by ABACON CAPITAL GmbH . The transaction toke place on 29th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 1.476.981,61 EUR, based on an average price of 14,77 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 29th March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th March 2023,
The Insider Transaction was made by Husmann, Dr. Christoph . The transaction toke place on 29th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 21.591,32 EUR, based on an average price of 14,54 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 29th March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th March 2023,
The Insider Transaction was made by Husmann, Dr. Christoph . The transaction toke place on 29th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 28.520,00 EUR, based on an average price of 14,26 EUR. The nature of the Investment was Buy.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 187 | 8th November 2024 | EQS Group AG | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 25 | 30th May 2024 | LMR Partners LLP | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.